SOPH
SOPHiA GENETICS S.A. NASDAQ Listed Jul 23, 2021$6.84
+20.21%
vs $5.69
Mkt Cap $462.0M
52w Low $3.01
100.0% of range
52w High $6.84
50d MA $5.50
200d MA $4.97
P/E (TTM)
-5.8x
EV/EBITDA
—
P/B
9.8x
Debt/Equity
1.3x
ROE
—
P/FCF
-12.0x
RSI (14)
67.00
ATR (14)
$0.43
Beta
1.04
50d MA
$5.50
200d MA
$4.97
Avg Volume
364.6K
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Rue du Centre 172 · Rolle, V8 1025 · CH
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | BMO | -0.21 | -0.26 | -23.8% | 5.69 | +6.3% | +20.2% | — | — | — | — | — |
| May 5, 2026 | BMO | -0.23 | -0.27 | -16.1% | 5.29 | -6.8% | -4.2% | -1.0% | +7.6% | -4.6% | -7.0% | — |
| Mar 3, 2026 | BMO | -0.24 | -0.28 | -17.9% | 4.10 | +0.5% | +2.9% | +0.0% | +2.6% | +0.5% | +2.5% | — |
| Nov 4, 2025 | BMO | -0.20 | -0.30 | -50.0% | 4.68 | -3.0% | -3.4% | +0.0% | +4.9% | -7.8% | -0.5% | — |
| Aug 5, 2025 | BMO | -0.21 | 0.33 | +257.1% | 3.42 | -7.9% | -7.9% | +0.0% | +1.6% | -0.6% | -5.3% | — |
| May 6, 2025 | BMO | -0.21 | -0.26 | -23.8% | 3.00 | +3.0% | +0.0% | +0.0% | -0.3% | -2.0% | +8.9% | — |
| Mar 4, 2025 | BMO | -0.23 | -0.23 | +0.0% | 3.10 | +5.5% | +0.3% | +0.0% | +0.0% | +4.2% | -0.9% | — |
| Nov 5, 2024 | BMO | -0.24 | -0.28 | -16.7% | 3.75 | -9.3% | -9.3% | +0.0% | +0.0% | +3.5% | +7.7% | — |
| Aug 6, 2024 | BMO | -0.28 | -0.23 | +17.9% | 4.06 | +0.0% | -10.1% | +0.0% | -7.9% | -3.6% | -1.5% | — |
| May 7, 2024 | BMO | -0.25 | -0.21 | +16.0% | 4.97 | +1.6% | -7.4% | +0.0% | +4.8% | -2.7% | -2.3% | — |
| Mar 5, 2024 | BMO | -0.25 | -0.37 | -48.0% | 5.60 | -8.0% | -10.5% | +0.0% | -0.4% | -5.2% | +2.5% | — |
| Nov 7, 2023 | BMO | -0.32 | -0.21 | +34.4% | 3.91 | -4.1% | +0.0% | +0.0% | -0.8% | -12.4% | -5.3% | — |
| Aug 8, 2023 | BMO | -0.29 | -0.33 | -13.8% | 3.55 | -2.5% | +1.7% | +0.0% | -6.4% | -9.2% | -2.3% | — |
| May 9, 2023 | BMO | -0.28 | -0.31 | -10.7% | 4.85 | +0.2% | -4.5% | +0.0% | +0.0% | -2.6% | -1.1% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20 | H.C. Wainwright | Initiates | Buy | $12 | $5.87 | $6.03 | +2.7% | +7.8% | +2.7% | -1.5% | -5.5% | -5.5% |
| Apr 15 | BTIG | Maintains | Buy → Buy | — | $4.96 | $4.96 | +0.0% | +2.2% | +1.0% | +3.1% | -1.7% | -1.3% |
| Jan 26 | Guggenheim | Maintains | Buy → Buy | — | $5.36 | $5.36 | +0.0% | -0.7% | -1.3% | +0.0% | -1.5% | +1.5% |
| Nov 10 | BTIG | Maintains | Buy → Buy | — | $4.37 | $4.37 | +0.0% | -0.5% | +6.2% | -6.5% | +1.4% | -1.6% |
| Aug 7 | RBC Capital | Maintains | Outperform → Outperform | — | $4.06 | $4.06 | +0.0% | -10.1% | -7.9% | -3.6% | -1.5% | +6.3% |
| Mar 6 | BTIG | Maintains | Buy → Buy | — | $5.60 | $5.15 | -8.0% | -10.5% | -0.4% | -5.2% | +2.5% | -3.9% |
| Mar 6 | RBC Capital | Maintains | Outperform → Outperform | — | $5.60 | $5.15 | -8.0% | -10.5% | -0.4% | -5.2% | +2.5% | -3.9% |
| Jan 12 | RBC Capital | Maintains | Outperform → Outperform | — | $5.50 | $5.46 | -0.7% | -4.9% | -12.6% | +0.4% | -1.7% | -0.2% |
| May 10 | Credit Suisse | Maintains | Neutral → Neutral | — | $4.85 | $4.86 | +0.2% | -4.5% | +0.0% | -2.6% | -1.1% | -5.2% |
| May 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.85 | $4.86 | +0.2% | -4.5% | +0.0% | -2.6% | -1.1% | -5.2% |
| Mar 8 | Morgan Stanley | Maintains | Overweight → Overweight | — | $2.53 | $2.60 | +2.8% | +21.7% | +7.8% | +4.2% | +4.9% | +37.5% |
| Jan 3 | BTIG | Maintains | Buy → Buy | — | $2.06 | $2.19 | +6.3% | +9.2% | -2.2% | -1.8% | -8.3% | +13.1% |
| Nov 23 | Credit Suisse | Maintains | Neutral → Neutral | — | $2.00 | $1.96 | -2.0% | +0.0% | +4.0% | -2.4% | +7.4% | +6.0% |
| Nov 9 | Morgan Stanley | Maintains | Overweight → Overweight | — | $1.84 | $1.76 | -4.3% | -7.1% | +17.0% | +14.0% | -10.5% | +0.5% |
| Aug 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.79 | $5.00 | +4.4% | +2.3% | +3.1% | -5.0% | -6.2% | -1.1% |
| May 11 | Morgan Stanley | Maintains | Overweight → Overweight | — | $4.91 | $5.00 | +1.8% | +6.5% | -5.2% | -3.0% | +0.2% | +3.3% |
| Mar 16 | Morgan Stanley | Maintains | Overweight → Overweight | — | $8.21 | $8.20 | -0.1% | +2.7% | +2.6% | -1.3% | -0.9% | -1.5% |
| Feb 15 | Morgan Stanley | Maintains | Overweight → Overweight | — | $11.59 | $11.73 | +1.2% | +5.1% | +0.9% | -1.1% | -4.1% | +2.9% |
| Aug 17 | Morgan Stanley | Maintains | Overweight → Overweight | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Aug 17 | JP Morgan | Maintains | Overweight → Overweight | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Aug 17 | Credit Suisse | Maintains | Outperform → Outperform | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Aug 17 | TD Cowen | Maintains | Outperform → Outperform | — | $18.09 | $18.10 | +0.1% | -2.4% | +2.4% | -3.4% | +3.0% | +1.1% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jul 13, 2026 | Xu ZhenyuOff | Chief Scientific Officer | Sell | 4,000 | $5.70 | $23K | 610,887 | +1.58% | +2.69% |
| Jul 13, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 5,000 | $5.70 | $29K | 228,387 | +1.58% | +2.69% |
| Jul 10, 2026 | Camblong JurgiDir/Off | Executive Chairman | Sell | 8,500 | $5.62 | $48K | 3,532,622 | +1.58% | +2.69% |
| Jul 7, 2026 | Camblong JurgiDir/Off | Executive Chairman | Sell | 17,685 | $5.28 | $93K | 3,541,122 | +5.63% | +1.58% |
| Jul 6, 2026 | Camblong JurgiDir/Off | Executive Chairman | Sell | 22,486 | $5.25 | $118K | 3,558,807 | +1.29% | -0.70% |
| Jul 6, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 7,393 | $5.16 | $38K | 233,387 | +1.29% | -0.70% |
| Jul 6, 2026 | Puylaert KevinOff | Chief Sales Officer | Sell | 31 | $5.09 | $158 | 147,948 | +1.29% | -0.70% |
| Jul 6, 2026 | Puylaert KevinOff | Chief Sales Officer | Sell | 47 | $5.03 | $236 | 147,979 | +1.29% | -0.70% |
| Jul 6, 2026 | Puylaert KevinOff | Chief Sales Officer | Sell | 138 | $5.03 | $693 | 148,026 | +1.29% | -0.70% |
| Jul 6, 2026 | Muken RossDir/Off | Chief Executive Officer | Sell | 9,838 | $5.22 | $51K | 670,651 | +1.29% | -0.70% |
| Jul 6, 2026 | Xu ZhenyuOff | Chief Scientific Officer | Sell | 7,393 | $5.17 | $38K | 614,887 | +1.29% | -0.70% |
| Jul 6, 2026 | Verma AbhimanyuOff | Chief Technology Officer | Sell | 5,285 | $5.10 | $27K | 192,171 | +1.29% | -0.70% |
| Jul 6, 2026 | Valente ManuelaOff | Chief People Officer | Sell | 4,241 | $5.05 | $21K | 210,450 | +1.29% | -0.70% |
| Jul 6, 2026 | CARDOZA GEORGEOff | Chief Financial Officer | Sell | 1,592 | $5.29 | $8K | 309,092 | +1.29% | -0.70% |
| Jun 30, 2026 | Camblong JurgiDir/Off | Executive Chairman | Sell | 200 | $6.30 | $1K | 3,581,293 | -4.29% | +5.63% |
| Jun 30, 2026 | Camblong JurgiDir/Off | Executive Chairman | Sell | 19,650 | $6.02 | $118K | 3,581,493 | -4.29% | +5.63% |
| Jun 30, 2026 | Camblong JurgiDir/Off | Executive Chairman | Sell | 45,419 | $6.14 | $279K | 3,601,143 | -4.29% | +5.63% |
| Jun 29, 2026 | Camblong JurgiDir/Off | Executive Chairman | Sell | 350 | $6.00 | $2K | 3,601,143 | -4.29% | +5.63% |
| Jun 29, 2026 | Camblong JurgiDir/Off | Executive Chairman | Sell | 18,060 | $5.87 | $106K | 3,601,493 | -4.29% | +5.63% |
| Jun 26, 2026 | Camblong JurgiDir/Off | Chief Executive Officer | Sell | 31,940 | $5.84 | $186K | 3,601,493 | -3.51% | +1.87% |
| Jun 26, 2026 | Camblong JurgiDir/Off | Chief Executive Officer | Sell | 18,129 | $5.73 | $104K | 3,601,493 | -3.51% | +1.87% |
| Jun 25, 2026 | Camblong JurgiDir/Off | Chief Executive Officer | Sell | 1,373 | $5.70 | $8K | 3,619,622 | -3.51% | +1.87% |
| Jun 25, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 5,000 | $5.50 | $28K | 240,780 | +4.00% | -0.19% |
| Jun 25, 2026 | Verma AbhimanyuOff | Chief Technology Officer | Sell | 6,944 | $5.51 | $38K | 197,456 | +4.00% | -0.19% |
| Jun 22, 2026 | Muken RossOff | President | Sell | 422 | $5.38 | $2K | 680,489 | +5.54% | -3.51% |
| Jun 22, 2026 | CARDOZA GEORGEOff | Chief Financial Officer | Sell | 774 | $5.38 | $4K | 310,684 | +5.54% | -3.51% |
| Jun 15, 2026 | Xu ZhenyuOff | Chief Scientific Officer | Sell | 4,000 | $5.01 | $20K | 622,280 | +4.20% | +3.08% |
| Jun 12, 2026 | Menu PhilippeOff | Chief Medical Officer | Sell | 5,000 | $4.95 | $25K | 245,780 | -1.60% | -2.06% |
| Jun 10, 2026 | Camblong JurgiDir/Off | Chief Executive Officer | Sell | 8,500 | $5.24 | $45K | 3,620,995 | -6.15% | +4.20% |
| Jun 5, 2026 | CARDOZA GEORGEOff | Chief Financial Officer | Buy | 20,000 | $4.95 | $99K | 311,458 | +5.60% | -6.15% |
No recent filings available.
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Generation Investment Management Llp | 6,789,560 | $34M | — | Mar 2026 |
| 2 | Akre Capital Management Llc | 3,719,140 | $18M | — | Mar 2026 |
| 3 | Soleus Capital Management, L.p. | 1,850,000 | $9M | New | Mar 2026 |
| 4 | Principal Financial Group Inc | 1,399,442 | $7M | Added | Dec 2025 |
| 5 | Essex Investment Management Co Llc | 692,809 | $3M | New | Mar 2026 |
| 6 | Ensign Peak Advisors, Inc | 444,954 | $2M | Added | Mar 2026 |
| 7 | Archon Capital Management Llc | 441,413 | $2M | — | Mar 2026 |
| 8 | Sei Investments Co | 357,888 | $2M | New | Mar 2026 |
| 9 | Legato Capital Management Llc | 216,341 | $1M | New | Mar 2026 |
| 10 | Rathbones Group Plc | 149,133 | $738K | Reduced | Mar 2026 |
| 11 | Ubs Group Ag | 92,226 | $457K | Added | Mar 2026 |
| 12 | Morgan Stanley | 96,094 | $449K | Added | Dec 2025 |
| 13 | Renaissance Technologies Llc | 59,800 | $296K | Reduced | Mar 2026 |
| 14 | Green Alpha Advisors, Llc | 42,952 | $213K | Reduced | Mar 2026 |
| 15 | Pathstone Holdings, Llc | 31,465 | $156K | Reduced | Mar 2026 |
| 16 | Franklin Resources Inc | 21,563 | $107K | New | Mar 2026 |
| 17 | Royal Bank Of Canada | 19,381 | $96K | Added | Mar 2026 |
| 18 | Susquehanna International Group, Llp | 13,156 | $65K | Reduced | Mar 2026 |
| 19 | Centiva Capital, Lp | 12,549 | $62K | New | Mar 2026 |
| 20 | Two Sigma Investments, Lp | 10,198 | $50K | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 2
All ↗
| # | Fund | Shares | Value | Period |
|---|---|---|---|---|
| 1 | SmallCap Fund | 689,000 | $4M | Jan 2026 |
| 2 | NORTH SQUARE KENNEDY MICROCAP FUND | 25,747 | $116K | Feb 2026 |
Valuation
Market Cap
$462.0M
Enterprise Value
$439.4M
P/E (TTM)
-5.80x
Forward P/E
—
PEG Ratio
-0.17x
P/B
9.80x
P/S
5.69x
P/FCF
-11.97x
EV/EBITDA
—
Shares Out
67.5M
Financials (TTM)
Revenue
$81.2M
Net Income
-$80.9M
EBITDA
-$66.1M
Free Cash Flow
-$38.6M
Op Cash Flow
-$38.0M
EPS Basic
$-1.17
EPS Diluted
$-1.18
EPS Forward
$-0.85
Gross Margin
67.3%
Op Margin
-88.4%
Net Margin
-99.7%
Balance Sheet
Total Assets
$163.5M
Total Liab.
$116.3M
Total Equity
$47.1M
Cash
$70.3M
LT Debt
$47.7M
Book Value/Sh
$0.70
Debt/Equity
1.34x
Current Ratio
1.96
Quick Ratio
1.84
Returns & Growth
ROE
—
ROA
—
ROIC
-61.3%
Rev Growth YoY
+18.6%
EPS Growth YoY
-23.2%
Price Returns
2W
-10.1%
1M
+6.6%
3M
+7.6%
6M
+13.8%
12M
+72.4%
Technicals
52W High
$6.84
52W Low
$3.01
50d MA
$5.50
200d MA
$4.97
RSI (14)
67.00
ATR (14)
$0.43
Beta
1.04
Avg Volume
365K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$7.50
High
$8.00
Low
$7.00
Median
$7.50
Data updated apr 27, 2026 2:27am
· Source: financialmodelingprep.com